Get startedLog in
    Picture of Lakewood-amedex Biotherapeutics logo

    LABT — Lakewood-amedex Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for Phase 2 Clinical Trial of Nu-3

    Picture of Lakewood-amedex Biotherapeutics logoLakewood-amedex Biotherapeutics
    12/05/2026 14:16
    May 12 (Reuters) - Lakewood-amedex Biotherapeutics Inc LABT.O:

LAKEWOOD-AMEDEX BIOTHERAPEUTICS ANNOUNCES AGREEMENT WITH PERI TO SERVE AS CRO FOR PHASE 2 CLINICAL TRIAL OF NU-3

Source text: ID:nPn11tDFTa

Further company coverage: LABT.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Lakewood-amedex Biotherapeutics

    See all news